A 61-year-old patient with no relevant medical or family history presented with a 2 month history of refractory dry cough that led to the diagnosis of typical carcinoid tumor of the lung ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Neuroendocrine Tumors ... non-squamous non-small cell lung cancer, sarcomas, cholangiocarcinoma, chronic lymphocytic ...

a CD3xDLL3 bispecific in phase 2 development for advanced or metastatic DLL3-expressing large-cell neuroendocrine carcinoma (NEC) of the lung, and MSD's MK-6070, a DLL3-targeting T-cell engager ...

North Carolina football player Tylee Craft was diagnosed in March 2022 with stage 4 large cell neuroendocrine carcinoma, a rare form of lung cancer, and the disease has spread to his brain ...